In this article, we are going to take a look at where Collegium Pharmaceutical, Inc. (NASDAQ:COLL) stands against the other small cap pharma stocks. Emily Field, Head of European Pharma Research ...

Collegium Pharmaceutical (COLL) reported $181.95 million in revenue for the quarter ended December 2024, representing a year-over-year increase of 21.5%. EPS of $1.77 for the same period compares ...

Feb. 27, 2025 (GLOBE NEWSWIRE) -- Collegium Pharmaceutical, Inc. (Nasdaq: COLL) today reported its financial results for the quarter and full year ended December 31, 2024, and provided a business ...

Feb. 27, 2025 (GLOBE NEWSWIRE) -- Collegium Pharmaceutical, Inc. (Nasdaq: COLL) today reported its financial results for the quarter and full year ended December 31, 2024, and provided a business ...

Analysts on Wall Street project that Collegium Pharmaceutical (COLL) will announce quarterly earnings of $1.54 per share in its forthcoming report, representing a decline of 2.5% year over year.

Pharmaceutical company Collegium Pharmaceutical (NASDAQ:COLL) will be reporting earnings tomorrow after the bell. Here’s what to look for. Collegium Pharmaceutical beat analysts’ revenue ...

On the morning of February 25, Russian troops attacked a border village in the Chernihiv region with unguided missiles, injuring a local resident and damaging a residential building. Viacheslav Chaus, ...

The Neubauer Collegium for Culture and Society has announced nine new projects for 2025-26. Each year Collegium projects bring together University faculty and other researchers to work through ...

4 A woman greets Ukrainian troops as they enter a recaptured town in the northern Chernihiv region on April 2, 2022. 5 Oleksandr, a military chaplain, blesses a Ukrainian soldier in the ...

The Collegium also recommended that Justice Manjusha Ajay Deshpande's term as an additional judge be renewed for a year. The Supreme Court Collegium has recommended that three additional judges of the ...